Simple Science

Cutting edge science explained simply

# Health Sciences# Genetic and Genomic Medicine

Advancements in Polygenic Risk Scores for Health Prediction

New frameworks enhance genetic risk assessments for better health outcomes.

― 4 min read


New Frameworks forNew Frameworks forGenetic Risk Scoresrisks using genetics.Improved methods for assessing health
Table of Contents

Polygenic Risk Scores (PRS) are tools used to predict how likely someone is to develop certain traits or health conditions based on their genetics. These scores come from analyzing many Genetic Variations, where specific data points, called risk alleles, are selected based on their impact on the trait in question. Researchers collect data from previous studies to weigh and sum these risk alleles, allowing them to create a score that reflects an individual’s genetic predisposition.

How PRS are Created

To create a PRS, researchers analyze large datasets, often from genome-wide association studies (GWAS). In these studies, they look for common genetic variants that contribute to specific traits such as height, weight, or diseases like diabetes or heart conditions. Once the risk alleles are identified in one group, researchers can apply this information to predict genetic risk in another group. The collection of data about risk alleles, along with the effects they have on traits, is crucial for calculating accurate PRS.

Limitations of Current PRS

Most PRS have been developed within specific groups of people, which can make them less reliable when applied to individuals outside those original groups. This limitation arises mainly due to the differences in population demographics, backgrounds, and environments. If a PRS is created using data from one population, it may not work as well for a different group. The result is that many PRS lack validation across different populations, which can reduce their usefulness in a clinical setting.

The Need for Better PRS

To improve the reliability of PRS, researchers are pooling data from different studies to create more inclusive risks scores that can be generalized across populations. One significant resource for this is the Polygenic Score Catalog, a public database that collects various PRS and their associated genetic information. This catalog allows researchers to replicate the scoring methods in different populations, which can enhance the accuracy of PRS.

The PRSmix Framework

To address the challenges of PRS, researchers developed a new framework called PRSmix. This method combines multiple PRS scores to improve the prediction of traits. PRSmix allows researchers to take advantage of existing scores from the same trait, which may capture more genetic variation than a single score could alone.

The Role of Pleiotropy in PRS

Pleiotropy refers to when one gene affects multiple traits. Understanding this concept helps improve PRS. The PRSmix+ framework goes a step further than PRSmix by combining scores from different, genetically related traits. This approach can boost prediction ability, making PRS more effective in identifying risks across various health conditions.

Assessing the New Frameworks

Researchers carried out extensive testing to evaluate the performance of PRSmix and PRSmix+. They focused on 47 traits in individuals of European descent and 32 traits in South Asian individuals. Several factors were considered during these assessments, including how much the new methods improved upon existing PRS and the sample size necessary for accurate predictions.

Results of the Evaluation

The results indicated that both PRSmix and PRSmix+ significantly enhanced prediction accuracy compared to existing methods. This improvement was particularly noticeable in traits that previously had low predictive power. For instance, certain heart conditions showed improvements in predictive accuracy when using the new PRS framework.

Clinical Applications of the New PRS

One major focus of this research was to apply the findings to real-world scenarios, especially in predicting coronary artery disease (CAD). CAD is a significant health issue, and by using the new PRSmix and PRSmix+ methods, researchers could better identify individuals at higher risk. The integrations of PRS with established Clinical Risk Factors significantly improved the ability to predict CAD risk.

Examination of Different Traits

Researchers also looked into various types of traits to see how the new frameworks performed across the board. They categorized traits into groups, such as weight, blood counts, and diseases like cancer. The findings showed consistent improvements in prediction accuracy across these categories, with the most significant gains observed in conditions that previously lacked robust risk scores.

Challenges and Future Perspectives

Despite the promising results, researchers identified several challenges. The majority of existing PRS were developed based predominantly on European ancestry groups, which can limit effectiveness in other populations. To enhance the applicability of PRS, continued emphasis on increasing the diversity of genetic studies is essential.

Conclusion

In conclusion, the PRSmix and PRSmix+ frameworks represent significant advancements in the field of genetic risk prediction. By combining existing PRS and leveraging the concept of pleiotropy, these new methods offer enhanced accuracy, which can improve clinical outcomes. As research progresses, there is hope for broader applications that can bridge the gap between genetic risk assessments and personalized medicine for diverse populations.

Original Source

Title: Integrative polygenic risk score improves the prediction accuracy of complex traits and diseases

Abstract: Polygenic risk scores (PRS) are an emerging tool to predict the clinical phenotypes and outcomes of individuals. Validation and transferability of existing PRS across independent datasets and diverse ancestries are limited, which hinders the practical utility and exacerbates health disparities. We propose PRSmix, a framework that evaluates and leverages the PRS corpus of a target trait to improve prediction accuracy, and PRSmix+, which incorporates genetically correlated traits to better capture the human genetic architecture. We applied PRSmix to 47 and 32 diseases/traits in European and South Asian ancestries, respectively. PRSmix demonstrated a mean prediction accuracy improvement of 1.20-fold (95% CI: [1.10; 1.3]; P-value = 9.17 x 10-5) and 1.19-fold (95% CI: [1.11; 1.27]; P-value = 1.92 x 10-6), and PRSmix+ improved the prediction accuracy by 1.72-fold (95% CI: [1.40; 2.04]; P-value = 7.58 x 10-6) and 1.42-fold (95% CI: [1.25; 1.59]; P-value = 8.01 x 10-7) in European and South Asian ancestries, respectively. Compared to the previously established cross-trait-combination method with scores from pre-defined correlated traits, we demonstrated that our method can improve prediction accuracy for coronary artery disease up to 3.27-fold (95% CI: [2.1; 4.44]; P-value after FDR correction = 2.6 x 10-4). Our method provides a comprehensive framework to benchmark and leverage the combined power of PRS for maximal performance in a desired target population.

Authors: Pradeep Natarajan, B. Truong, L. E. Hull, Y. Ruan, Q. Q. Huang, W. Hornsby, H. C. Martin, D. A. van Heel, Y. Wang, A. R. Martin, H. Lee

Last Update: 2023-03-23 00:00:00

Language: English

Source URL: https://www.medrxiv.org/content/10.1101/2023.02.21.23286110

Source PDF: https://www.medrxiv.org/content/10.1101/2023.02.21.23286110.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to medrxiv for use of its open access interoperability.

More from authors

Similar Articles